We review below the evidence from the literature about the relationships between bacterial vaginosis, its treatment and pregnancy outcome. The literature indicates that there is a well-defined association between the presence of bacterial vaginosis during pregnancy and the risk of premature membrane rupture and preterm birth. Less definite is the role of the treatment of such pathology in reducing the frequency of preterm birth and/or premature rupture of membranes. The results of the controlled clinical trials are not entirely consistent. Of the most studied therapies, clindamycin seems to have shown favourable results most consistently but the published data are limited to trials including just a few hundred subjects. Only the availability of further data from controlled clinical trials will clarify the role of such treatment for bacterial vaginosis in pregnancy.
GravettMGHummelDEschenbachDA: Preterm labor association with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol1986a; 67: 229–237.
2.
GravettMGNelsonHPDe RouenT: Independent association of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA1986b; 256: 1899–1903.
3.
GardnerHLDukesCD: Haemophilus vaginalis vaginitis. Am J Obstet Gynecol1995; 69: 962–976.
4.
SpiegelCAAmselREschenbachDA: Anaerobic bacteria in nonspecific vaginitis. N Engl J Med1980; 303: 601–607.
5.
PiotPVan DyckEGodtsP: The vaginal microbial flora in nonspecific vaginitis. Eur J Clin Microbiol1982; 1: 301–306.
EschenbachDADavickPRWilliamsBL: Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol1989; 27: 251–256.
8.
HillGB: The microbiology of bacterial vaginosis. Am J Obstet Gynecol1993; 169: 450–454.
9.
AmselRTottenPASpiegelCA: Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic association. Am J Med1983; 74: 14–22.
10.
SpiegelCAAmselRHolmesKK: Diagnosis of bacterial vaginosis by direct Gram stain of vaginal fluid. J Clin Microbiol1983; 18: 170–177.
11.
HayPETaylor-RobinsonDLamontRF: Diagnosis of bacterial vaginosis in a gynaecology clinic. Br J Obstet Gynaecol1992; 99: 63–66.
12.
MartiusJKrohnMAHillierSL: Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol1988; 71: 89–95.
13.
EschenbachDAHillierSCritcholowC: Diagnosis and clinical manifestation of bacterial vaginosis. Am J Obstet Gynecol1988; 158: 819–828.
14.
MeadPB: Epidemiology of bacterial vaginosis. Am J Obstet Gynecol1993; 169: 446–449.
15.
McGregorJAFrenchJIRichterR: Antenatal microbiologic and maternal risk factors associated with prematurity. Am J Obstet Gynecol1990; 163: 1465–1473.
16.
KurkiTSivonenARenkonenOV: Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol1992; 80: 173–177.
17.
LamontRFTaylor-RobinsonDNewmanM: Spontaneous early preterm labor associated with abnormal genital bacterial colonization. Br J Obstet Gynaecol1986; 93: 804–810.
SilverHMSperlingRSSt. ClairPJ: Evidence relating bacterial vaginosis to intraamniotic infection. Am J Obstet Gynecol1989; 161: 808–812.
20.
HillierSLNugentRPEschenbachDA. For the Vaginal Infections and Prematurity Study Group: Association between bacteria vaginosis and preterm delivery of a low-birth-weight infant. N Engl J Med1995; 333: 1737–1742.
21.
McGregorJAFrenchJIRellerLB: Adjunctive erythromycin treatment for idiopathic preterm labor: results of a randomized, double-blinded, placebo-controlled trial. Am J Obstet Gynecol1986; 154: 98–103.
22.
McGregorJAFrenchJISeoK: Adjunctive clindamycin therapy for preterm labor: results of a double-blind, placebo-controlled trial. Am J Obstet Gynecol1991; 165: 867–875.
23.
SchwartzBESchultzFMMacDonaldPC: Initiation of human parturition: IV. Demonstration of phospholipase A2 in the lysosomes of human fetal membranes. Am J Obstet Gynecol1976; 125: 1089.
24.
McGregorJAFrenchJIJonesW: Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: result of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol1994; 170: 1048–1060.
25.
McNabbPCTomasiTB: Host defense mechanisms at mucosal surfaces. Ann Rev Microbiol1981; 35: 477–496.
26.
CohenMSBlackJRProctorRA: Host defenses and the vaginal mucosa: a re-evaluation. Scand J Urol Nephrol Suppl1984; 86: 13–22.
27.
ReutterWEKottgenEBaverC: Biologic significance of sialic acids. In: Sialic Acids: Chemistry, Metabolism and Function (ShaverR, ed). Cell Biology Monographs, Vol. 10. New York: Springer-Verlag, 1982; pp 263–305.
28.
ElderHASantamarinaBAGSmithS: The natural history of asymptomatic bacteriuria during pregnancy: The effect of tetracycline on the clinical course and the outcome of pregnancy. Am J Obstet Gynecol1971; 111: 441–462.
29.
McCormackWMRosnerBLeeYH: Effect on birth weight of erythromycin treatment of pregnant women. Obstet Gynecol1987; 69: 202–207.
30.
NewtonERDinsmoorMJGibbsRS: A randomized, blinded, placebo-controlled trial of antibiotics in idiopathic preterm labor. Obstet Gynecol1989; 74: 562–566.
31.
MoralesWJAngelJLO'BrienWF: A randomized study of antibiotic therapy in idiopathic preterm labor. Obstet Gynecol1988; 72: 829–833.
32.
McGregorJAFrenchJIParkerR: Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol1995; 173: 157–167.
33.
MoralesWJSchorrSAlbrittonJ: Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am J Obstet Gynecol1994; 171: 345–349.
34.
HauthJCGoldenbergRLAndrewsWW: Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med1995; 333: 1732–1736.
35.
RomeroRSibaiBCaritisS: Antibiotic treatment of preterm labor with intact membranes: a multicenter, randomized, double-blinded, placebo-controlled trial. Am J Obstet Gynecol1993; 169: 764–774.
